Does Hims take insurance for weight loss?

In our data Hims runs a cash-pay model for the GLP-1 weight track, so there's no insurance billing. If using insurance benefits matters to you, a provider like Ro or Found is a better starting point.

Does Hims offer branded or compounded GLP-1?

Our provider data lists compounded semaglutide and tirzepatide for the weight track — compounding-pharmacy products, not the FDA-approved branded drugs. Confirm the exact medication and its source during intake.

How much does the Hims weight program cost?

Hims doesn't publish a clear all-in GLP-1 price before intake in our data. Confirm the full monthly cost, including how it steps up at higher doses, during the intake.

Is Hims & Hers legit?

FDA has 2 warning letters on record against Hims & Hers Health, Inc., the company behind hims.com — letters 716567 and 716825, issued September 9, 2025; all are linked further down this page. On this desk a warning letter discloses, it does not disqualify. Hims & Hers is a GLP-1 telehealth service you reach through a video visit with a clinician and an online intake a clinician reviews. The medications it names are Semaglutide and Tirzepatide. What it publishes up front: From $149/mo for medication plus a required membership ($39 first month, then $149/mo) — about $298/mo all-in. It is cash-pay and states it does not bill insurance. What our record does not establish: which states it serves and a single monthly price you can check before an intake. Ask for those in writing before you pay.

Updated July 2026

Hims & Hers review

Mainstream, app-first

A mainstream consumer brand with an app-first weight program built around compounded GLP-1 and ongoing support.

Our verdict

Hims & Hers is the recognizable, app-first choice — a slick mobile experience and ongoing clinical support around compounded semaglutide and tirzepatide. It's cash-pay in our data and doesn't publish an all-in price up front, so treat it as a convenience-and-brand play rather than a cost leader.

Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.

Check availability →From $149/mo for medication plus a required membership ($39 first month, then $149/mo) — about $298/mo all-in

2 FDA warning letters on record — public record, does not change our verdict.

At a glance

Category: GLP-1 telehealth
Access: From $149/mo for medication plus a required membership ($39 first month, then $149/mo) — about $298/mo all-in
Medications: Semaglutide · Tirzepatide
Insurance: Cash-pay, no insurance
Visit: Video visit / Async intake
FDA: 2 warning letters on record
Updated: July 2026

What it is

Hims & Hers is a widely used consumer telehealth brand whose weight-management track offers GLP-1 medication with ongoing clinical support, delivered through a heavily app-based experience.

How it works

The experience is built around the app — video or asynchronous visits, prescribing, refills, and check-ins all run through it. That's convenient and familiar, but it's a consumer-brand model rather than a dedicated obesity-medicine practice.

Pricing transparency

Hims doesn't publish a clear all-in GLP-1 price before intake in our data, and it's a cash-pay service — no insurance billing. Confirm the full monthly cost, including how it changes as your dose climbs, before committing.

Branded vs compounded

Our provider data lists compounded semaglutide and tirzepatide for the weight track — these are compounding-pharmacy products, not the FDA-approved branded drugs. Confirm the exact medication and its source during intake before you start.

FDA warning letters on record

The FDA has issued 2 warning letters naming Hims & Hers Health, Inc., the company behind hims.com — the site this review covers.

Letter 716567, issued September 9, 2025 — read it on fda.gov
Letter 716825, issued September 9, 2025 — read it on fda.gov

We publish this because it is a matter of public record and a reader weighing this provider should have it. A warning letter is the FDA setting out alleged violations; it is not a court finding, and a company may have responded or corrected since. It does not remove Hims & Hers from our rankings, and it does not change our verdict — read the letter and decide for yourself.

Pros and watch-outs

What we like

Polished, app-first experience from a mainstream brand
Ongoing clinical support, not a one-off script
Video and asynchronous visit options
Familiar, widely-used consumer platform

Watch-outs

Cash-pay — no insurance billing in our data
All-in pricing isn't published up front
Compounded medication, not FDA-approved branded

Best for

People who want a familiar, app-driven experience from a mainstream brand and don't need insurance billing.

Who should look elsewhere

Anyone who wants branded medication, insurance coverage, or fully upfront pricing.

The evidence behind what Hims & Hers prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

What the semaglutide weight-loss trials actually showed
STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.
SURMOUNT-1 explained: the trial that made tirzepatide the benchmark
The landmark phase 3 trial of tirzepatide for obesity — the design, the up-to-20.9% weight loss, the safety profile, and the limits of what it proved.

How Hims & Hers compares

A few alternatives worth a look, depending on what you’re optimizing for.

Ro
A polished, well-resourced end-to-end program
See Ro →
Found
Putting insurance benefits toward GLP-1 treatment
See Found →
Mochi Health
A clinician-led, titration-focused program
See Mochi Health →

Compare all providers side by side →

More GLP-1 telehealth reviews: Gala HealthDirect MedsStrut HealthCoreAge RxOak LongevityCareBareRX

Nadia Feldman

Access & cost · Reviewed and last verified July 2026

How we assessed this. This review reflects Aminoscope’s own read of Hims & Hers’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.

Frequently asked

Does Hims take insurance for weight loss?: In our data Hims runs a cash-pay model for the GLP-1 weight track, so there's no insurance billing. If using insurance benefits matters to you, a provider like Ro or Found is a better starting point.
Does Hims offer branded or compounded GLP-1?: Our provider data lists compounded semaglutide and tirzepatide for the weight track — compounding-pharmacy products, not the FDA-approved branded drugs. Confirm the exact medication and its source during intake.
How much does the Hims weight program cost?: Hims doesn't publish a clear all-in GLP-1 price before intake in our data. Confirm the full monthly cost, including how it steps up at higher doses, during the intake.
Is Hims & Hers legit?: FDA has 2 warning letters on record against Hims & Hers Health, Inc., the company behind hims.com — letters 716567 and 716825, issued September 9, 2025; all are linked further down this page. On this desk a warning letter discloses, it does not disqualify. Hims & Hers is a GLP-1 telehealth service you reach through a video visit with a clinician and an online intake a clinician reviews. The medications it names are Semaglutide and Tirzepatide. What it publishes up front: From $149/mo for medication plus a required membership ($39 first month, then $149/mo) — about $298/mo all-in. It is cash-pay and states it does not bill insurance. What our record does not establish: which states it serves and a single monthly price you can check before an intake. Ask for those in writing before you pay.

Check availability →

Or compare every GLP-1 provider.